{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:27:01Z","timestamp":1793413621384,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Piano di Sostegno per la Ricerca, Universita` degli Studi di Milano,","award":["Piano di Sostegno per la Ricerca, Universita` degli Studi di Milano,"],"award-info":[{"award-number":["Piano di Sostegno per la Ricerca, Universita` degli Studi di Milano,"]}]},{"name":"Progetti di rilevante interesse nazionale","award":["20228XHTBZ"],"award-info":[{"award-number":["20228XHTBZ"]}]},{"name":"Progetti di rilevante interesse nazionale","award":["20222LRHCW"],"award-info":[{"award-number":["20222LRHCW"]}]},{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["Department of Excellence, 2023\u20132027"],"award-info":[{"award-number":["Department of Excellence, 2023\u20132027"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Leucine-rich repeat kinase 2 (LRRK2) encodes a multidomain protein whose mutations have been identified as genetic risk factors for Parkinson\u2019s disease (PD), an age-related neurodegenerative disorder. Outside the nervous system, LRRK2 is expressed in multiple tissues, including the endocrine pancreas, but its role here is unknown. Using pharmacological and molecular approaches, we show that LRRK2 kinase activity regulates stimulated insulin secretion by influencing secretory granule trafficking. The PD-associated LRRK2 mutant G2019S, characterized by enhanced kinase activity, increases the basal insulin release in complementary in vitro models and affects the metabolic profile in transgenic mice. Mechanistically, we demonstrate that LRRK2 kinase activity influences the formation of the primary cilium, an antenna-like structure acting as signaling platform to regulate hormones secretion. Specifically, LRRK2 phosphorylates RAB8 in a glucose-dependent manner, facilitating its recruitment to the primary cilium. These findings identify LRRK2 as a regulator of insulin secretion in pancreatic \u03b2-cells. Given the role of insulin signaling and glucose homeostasis in the nervous system, our data suggest that LRRK2 may also contribute to PD development through peripheral action.<\/jats:p>","DOI":"10.1007\/s00018-025-05810-w","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:09:15Z","timestamp":1752775755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["LRRK2 kinase modulates glucose-stimulated insulin secretion via RAB8 phosphorylation and ciliogenesis"],"prefix":"10.1007","volume":"82","author":[{"given":"Nevia","family":"Dule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Algerta","family":"Marku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pischedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Marciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-1779","authenticated-orcid":false,"given":"Carla","family":"Perego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"5810_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrn2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in parkinson\u2019s disease. Nat Rev Neurosci 11:791\u2013797. https:\/\/doi.org\/10.1038\/nrn2935","journal-title":"Nat Rev Neurosci"},{"key":"5810_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-49969-7_1","volume":"14","author":"E Monfrini","year":"2017","unstructured":"Monfrini E, Di Fonzo A (2017) Leucine-Rich repeat kinase (LRRK2) genetics and parkinson\u2019s disease. Adv Neurobiol 14:3\u201330. https:\/\/doi.org\/10.1007\/978-3-319-49969-7_1","journal-title":"Adv Neurobiol"},{"key":"5810_CR3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG et al (2017) Past, present, and future of parkinson\u2019s disease: A special essay on the 200th anniversary of the shaking palsy. Mov Disord 32:1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Mov Disord"},{"key":"5810_CR4","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1136\/jmg.2005.035568","volume":"42","author":"S Goldwurm","year":"2005","unstructured":"Goldwurm S, Di Fonzo A, Simons EJ et al (2005) The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset parkinson\u2019s disease and originates from a common ancestor. J Med Genet 42:e65. https:\/\/doi.org\/10.1136\/jmg.2005.035568","journal-title":"J Med Genet"},{"key":"5810_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","volume":"23","author":"E Greggio","year":"2006","unstructured":"Greggio E, Jain S, Kingsbury A et al (2006) Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin. Neurobiol Dis 23:329\u2013341. https:\/\/doi.org\/10.1016\/j.nbd.2006.04.001","journal-title":"Neurobiol Dis"},{"key":"5810_CR6","doi-asserted-by":"publisher","first-page":"e12813","DOI":"10.7554\/eLife.12813","volume":"5","author":"M Steger","year":"2016","unstructured":"Steger M, Tonelli F, Ito G et al (2016) Phosphoproteomics reveals that parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases. eLife 5:e12813. https:\/\/doi.org\/10.7554\/eLife.12813","journal-title":"eLife"},{"key":"5810_CR7","doi-asserted-by":"publisher","first-page":"105806","DOI":"10.1016\/j.nbd.2022.105806","volume":"172","author":"G Tsafaras","year":"2022","unstructured":"Tsafaras G, Baekelandt V (2022) The role of LRRK2 in the periphery: link with parkinson\u2019s disease and inflammatory diseases. Neurobiol Dis 172:105806. https:\/\/doi.org\/10.1016\/j.nbd.2022.105806","journal-title":"Neurobiol Dis"},{"key":"5810_CR8","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1038\/s41598-019-40808-y","volume":"9","author":"N Funk","year":"2019","unstructured":"Funk N, Munz M, Ott T et al (2019) The parkinson\u2019s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4. Sci Rep 9:4515. https:\/\/doi.org\/10.1038\/s41598-019-40808-y","journal-title":"Sci Rep"},{"key":"5810_CR9","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1248\/bpb.b20-00377","volume":"43","author":"M Imai","year":"2020","unstructured":"Imai M, Kawakami F, Kubo M et al (2020) LRRK2 Inhibition ameliorates Dexamethasone-Induced glucose intolerance via prevents impairment in GLUT4 membrane translocation in adipocytes. Biol Pharm Bull 43:1660\u20131668. https:\/\/doi.org\/10.1248\/bpb.b20-00377","journal-title":"Biol Pharm Bull"},{"key":"5810_CR10","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/2211-5463.13717","volume":"13","author":"F Kawakami","year":"2023","unstructured":"Kawakami F, Imai M, Isaka Y et al (2023) LRRK2 negatively regulates glucose tolerance via regulation of membrane translocation of GLUT4 in adipocytes. FEBS Open Bio 13:2200\u20132214. https:\/\/doi.org\/10.1002\/2211-5463.13717","journal-title":"FEBS Open Bio"},{"key":"5810_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Pais\u00e1n-Ru\u00edz","year":"2004","unstructured":"Pais\u00e1n-Ru\u00edz C, Jain S, Evans EW et al (2004) Cloning of the gene containing mutations that cause PARK8-linked parkinson\u2019s disease. Neuron 44:595\u2013600. https:\/\/doi.org\/10.1016\/j.neuron.2004.10.023","journal-title":"Neuron"},{"key":"5810_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145\u2013146","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) Insulin resistance and parkinson\u2019s disease: A new target for disease modification? Prog Neurobiol 145\u2013146:98\u2013120. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.10.001","journal-title":"Prog Neurobiol"},{"key":"5810_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590. https:\/\/doi.org\/10.1016\/S1474-4422(08)70117-0","journal-title":"Lancet Neurol"},{"key":"5810_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/jcp.25176","volume":"231","author":"ES Di Cairano","year":"2016","unstructured":"Di Cairano ES, Moretti S, Marciani P et al (2016) Neurotransmitters and neuropeptides: new players in the control of islet of langerhans\u2019 cell mass and function. J Cell Physiol 231:756\u2013767. https:\/\/doi.org\/10.1002\/jcp.25176","journal-title":"J Cell Physiol"},{"key":"5810_CR15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1210\/endo.137.4.8625909","volume":"137","author":"MB Wheeler","year":"1996","unstructured":"Wheeler MB, Sheu L, Ghai M et al (1996) Characterization of SNARE protein expression in beta cell lines and pancreatic Islets. Endocrinology 137:1340\u20131348. https:\/\/doi.org\/10.1210\/endo.137.4.8625909","journal-title":"Endocrinology"},{"issue":"Pt 9","key":"5810_CR16","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1242\/jcs.109.9.2265","volume":"109","author":"R Regazzi","year":"1996","unstructured":"Regazzi R, Ravazzola M, Iezzi M et al (1996) Expression, localization and functional role of small GTPases of the Rab3 family in insulin-secreting cells. J Cell Sci 109(Pt 9):2265\u20132273","journal-title":"J Cell Sci"},{"key":"5810_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/biom13020224","volume":"13","author":"A Galli","year":"2023","unstructured":"Galli A, Arunagiri A, Dule N et al (2023) Cholesterol redistribution in pancreatic \u03b2-Cells: A flexible path to regulate insulin secretion. Biomolecules 13:224. https:\/\/doi.org\/10.3390\/biom13020224","journal-title":"Biomolecules"},{"key":"5810_CR18","doi-asserted-by":"publisher","first-page":"e202108101","DOI":"10.1083\/jcb.202108101","volume":"222","author":"GM Sanchez","year":"2023","unstructured":"Sanchez GM, Incedal TC, Prada J et al (2023) The \u03b2-cell primary cilium is an autonomous Ca2\u2009+\u2009compartment for paracrine GABA signaling. J Cell Biol 222:e202108101. https:\/\/doi.org\/10.1083\/jcb.202108101","journal-title":"J Cell Biol"},{"key":"5810_CR19","doi-asserted-by":"publisher","first-page":"eabq8486","DOI":"10.1126\/sciadv.abq8486","volume":"8","author":"JH Cho","year":"2022","unstructured":"Cho JH, Li ZA, Zhu L et al (2022) Islet primary cilia motility controls insulin secretion. Sci Adv 8:eabq8486. https:\/\/doi.org\/10.1126\/sciadv.abq8486","journal-title":"Sci Adv"},{"key":"5810_CR20","doi-asserted-by":"publisher","first-page":"922825","DOI":"10.3389\/fendo.2022.922825","volume":"13","author":"M Pablos","year":"2022","unstructured":"Pablos M, Casanueva-\u00c1lvarez E, Gonz\u00e1lez-Casimiro CM et al (2022) Primary cilia in pancreatic \u03b2- and \u03b1-Cells: time to revisit the role of Insulin-Degrading enzyme. Front Endocrinol (Lausanne) 13:922825. https:\/\/doi.org\/10.3389\/fendo.2022.922825","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5810_CR21","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1042\/BST20201146","volume":"49","author":"G Piccoli","year":"2021","unstructured":"Piccoli G, Volta M (2021) LRRK2 along the golgi and lysosome connection: a jamming situation. Biochem Soc Trans 49:2063\u20132072. https:\/\/doi.org\/10.1042\/BST20201146","journal-title":"Biochem Soc Trans"},{"key":"5810_CR22","doi-asserted-by":"publisher","first-page":"167998","DOI":"10.1016\/j.jmb.2023.167998","volume":"435","author":"CA Boecker","year":"2023","unstructured":"Boecker CA (2023) The role of LRRK2 in intracellular organelle dynamics. J Mol Biol 435:167998. https:\/\/doi.org\/10.1016\/j.jmb.2023.167998","journal-title":"J Mol Biol"},{"key":"5810_CR23","doi-asserted-by":"publisher","first-page":"e40202","DOI":"10.7554\/eLife.40202","volume":"7","author":"HS Dhekne","year":"2018","unstructured":"Dhekne HS, Yanatori I, Gomez RC et al (2018) A pathway for parkinson\u2019s disease LRRK2 kinase to block primary cilia and Sonic Hedgehog signaling in the brain. Elife 7:e40202. https:\/\/doi.org\/10.7554\/eLife.40202","journal-title":"Elife"},{"key":"5810_CR24","doi-asserted-by":"publisher","first-page":"F495","DOI":"10.1152\/ajprenal.00198.2010","volume":"299","author":"CM Babbey","year":"2010","unstructured":"Babbey CM, Bacallao RL, Dunn KW (2010) Rab10 associates with primary cilia and the exocyst complex in renal epithelial cells. Am J Physiol Ren Physiol 299:F495\u2013506. https:\/\/doi.org\/10.1152\/ajprenal.00198.2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"5810_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/21541248.2017.1353847","volume":"9","author":"OE Blacque","year":"2018","unstructured":"Blacque OE, Scheidel N, Kuhns S (2018) Rab GTPases in cilium formation and function. Small GTPases 9:76\u201394. https:\/\/doi.org\/10.1080\/21541248.2017.1353847","journal-title":"Small GTPases"},{"key":"5810_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrm3085","volume":"12","author":"H Ishikawa","year":"2011","unstructured":"Ishikawa H, Marshall WF (2011) Ciliogenesis: Building the cell\u2019s antenna. Nat Rev Mol Cell Biol 12:222\u2013234. https:\/\/doi.org\/10.1038\/nrm3085","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5810_CR27","doi-asserted-by":"publisher","first-page":"e87098","DOI":"10.7554\/eLife.87098","volume":"12","author":"HS Dhekne","year":"2023","unstructured":"Dhekne HS, Tonelli F, Yeshaw WM et al (2023) Genome-wide screen reveals Rab12 GTPase as a critical activator of parkinson\u2019s disease-linked LRRK2 kinase. Elife 12:e87098. https:\/\/doi.org\/10.7554\/eLife.87098","journal-title":"Elife"},{"key":"5810_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2016.00035","volume":"9","author":"C Bedford","year":"2016","unstructured":"Bedford C, Sears C, Perez-Carrion M et al (2016) LRRK2 regulates Voltage-Gated calcium channel function. Front Mol Neurosci 9:35. https:\/\/doi.org\/10.3389\/fnmol.2016.00035","journal-title":"Front Mol Neurosci"},{"key":"5810_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-018-0235-y","volume":"13","author":"J Madero-P\u00e9rez","year":"2018","unstructured":"Madero-P\u00e9rez J, Fdez E, Fern\u00e1ndez B et al (2018) Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation. Mol Neurodegener 13:3. https:\/\/doi.org\/10.1186\/s13024-018-0235-y","journal-title":"Mol Neurodegener"},{"key":"5810_CR30","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1600-0854.2011.01231.x","volume":"12","author":"K Hatlapatka","year":"2011","unstructured":"Hatlapatka K, Matz M, Schumacher K et al (2011) Bidirectional insulin granule turnover in the submembrane space during K(+) depolarization-induced secretion. Traffic 12:1166\u20131178. https:\/\/doi.org\/10.1111\/j.1600-0854.2011.01231.x","journal-title":"Traffic"},{"key":"5810_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","volume":"40","author":"HL Melrose","year":"2010","unstructured":"Melrose HL, D\u00e4chsel JC, Behrouz B et al (2010) Impaired dopaminergic neurotransmission and microtubule-associated protein Tau alterations in human LRRK2 Transgenic mice. Neurobiol Dis 40:503\u2013517. https:\/\/doi.org\/10.1016\/j.nbd.2010.07.010","journal-title":"Neurobiol Dis"},{"key":"5810_CR32","doi-asserted-by":"publisher","first-page":"155291","DOI":"10.1016\/j.metabol.2022.155291","volume":"136","author":"A Marku","year":"2022","unstructured":"Marku A, Da Dalt L, Galli A et al (2022) Pancreatic PCSK9 controls the organization of the \u03b2-cell secretory pathway via LDLR-cholesterol axis. Metabolism 136:155291. https:\/\/doi.org\/10.1016\/j.metabol.2022.155291","journal-title":"Metabolism"},{"key":"5810_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00007890-198809000-00026","volume":"46","author":"C Ricordi","year":"1988","unstructured":"Ricordi C, Finke EH, Dye ES et al (1988) AUTOMATED ISOLATION OF MOUSE PANCREATIC ISLETS. Transplantation 46:455\u2013456. https:\/\/doi.org\/10.1097\/00007890-198809000-00026","journal-title":"Transplantation"},{"key":"5810_CR34","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.1152\/ajpendo.00069.2024","volume":"327","author":"A Galli","year":"2024","unstructured":"Galli A, Moretti S, Dule N et al (2024) Hyperglycaemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in Islets of langerhans: implications for type 2 diabetes pathogenesis and treatment. Am J Physiology-Endocrinology Metabolism 327:E27\u2013E41. https:\/\/doi.org\/10.1152\/ajpendo.00069.2024","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"5810_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/biomedicines8120582","volume":"8","author":"A Galli","year":"2020","unstructured":"Galli A, Marciani P, Marku A et al (2020) Verbascoside protects pancreatic \u03b2-Cells against ER-Stress. Biomedicines 8:582. https:\/\/doi.org\/10.3390\/biomedicines8120582","journal-title":"Biomedicines"},{"key":"5810_CR36","doi-asserted-by":"publisher","first-page":"106130","DOI":"10.1016\/j.phrs.2022.106130","volume":"177","author":"C Perego","year":"2022","unstructured":"Perego C, Di Cairano ES, Galli A et al (2022) Autoantibodies against the glial glutamate transporter GLT1\/EAAT2 in type 1 diabetes mellitus\u2014Clues to novel immunological and non-immunological therapies. Pharmacol Res 177:106130. https:\/\/doi.org\/10.1016\/j.phrs.2022.106130","journal-title":"Pharmacol Res"},{"key":"5810_CR37","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/brain\/awab073","volume":"144","author":"F Pischedda","year":"2021","unstructured":"Pischedda F, Cirnaru MD, Ponzoni L et al (2021) LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation. Brain 144:1509\u20131525. https:\/\/doi.org\/10.1093\/brain\/awab073","journal-title":"Brain"},{"key":"5810_CR38","doi-asserted-by":"publisher","first-page":"D544","DOI":"10.1093\/nar\/gki095","volume":"33","author":"LJ Smink","year":"2005","unstructured":"Smink LJ, Helton EM, Healy BC et al (2005) T1DBase, a community web-based resource for type 1 diabetes research. Nucleic Acids Res 33:D544\u2013549. https:\/\/doi.org\/10.1093\/nar\/gki095","journal-title":"Nucleic Acids Res"},{"key":"5810_CR39","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1038\/s41598-017-05760-9","volume":"7","author":"MDP Carrion","year":"2017","unstructured":"Carrion MDP, Marsicano S, Daniele F et al (2017) The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions. Sci Rep 7:5377. https:\/\/doi.org\/10.1038\/s41598-017-05760-9","journal-title":"Sci Rep"},{"key":"5810_CR40","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1038\/s41598-020-60834-5","volume":"10","author":"A Marku","year":"2020","unstructured":"Marku A, Carrion MDP, Pischedda F et al (2020) The LRRK2 N-terminal domain influences vesicle trafficking: impact of the E193K variant. Sci Rep 10:3799. https:\/\/doi.org\/10.1038\/s41598-020-60834-5","journal-title":"Sci Rep"},{"key":"5810_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jnc.15240","volume":"157","author":"F Pischedda","year":"2021","unstructured":"Pischedda F, Piccoli G (2021) LRRK2 at the pre-synaptic site: A 16-years perspective. J Neurochem 157:297\u2013311. https:\/\/doi.org\/10.1111\/jnc.15240","journal-title":"J Neurochem"},{"key":"5810_CR42","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.1016\/j.bmcl.2012.06.104","volume":"22","author":"AD Reith","year":"2012","unstructured":"Reith AD, Bamborough P, Jandu K et al (2012) GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor. Bioorg Med Chem Lett 22:5625\u20135629. https:\/\/doi.org\/10.1016\/j.bmcl.2012.06.104","journal-title":"Bioorg Med Chem Lett"},{"key":"5810_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.115.227587","volume":"355","author":"MJ Fell","year":"2015","unstructured":"Fell MJ, Mirescu C, Basu K et al (2015) MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase Inhibition. J Pharmacol Exp Ther 355:397\u2013409. https:\/\/doi.org\/10.1124\/jpet.115.227587","journal-title":"J Pharmacol Exp Ther"},{"key":"5810_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ceb.2020.01.001","volume":"63","author":"M Taylor","year":"2020","unstructured":"Taylor M, Alessi DR (2020) Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and parkinson\u2019s disease. Curr Opin Cell Biol 63:102\u2013113. https:\/\/doi.org\/10.1016\/j.ceb.2020.01.001","journal-title":"Curr Opin Cell Biol"},{"key":"5810_CR45","doi-asserted-by":"publisher","first-page":"e31012","DOI":"10.7554\/eLife.31012","volume":"6","author":"M Steger","year":"2017","unstructured":"Steger M, Diez F, Dhekne HS et al (2017) Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. Elife 6:e31012. https:\/\/doi.org\/10.7554\/eLife.31012","journal-title":"Elife"},{"key":"5810_CR46","doi-asserted-by":"publisher","first-page":"15485","DOI":"10.1074\/jbc.R500003200","volume":"280","author":"SR Pfeffer","year":"2005","unstructured":"Pfeffer SR (2005) Structural clues to Rab GTPase functional diversity. J Biol Chem 280:15485\u201315488. https:\/\/doi.org\/10.1074\/jbc.R500003200","journal-title":"J Biol Chem"},{"key":"5810_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrm2728","volume":"10","author":"H Stenmark","year":"2009","unstructured":"Stenmark H (2009) Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10:513\u2013525. https:\/\/doi.org\/10.1038\/nrm2728","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5810_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-0716-1346-7_7","volume-title":"Rab GTPases","author":"Q Lu","year":"2021","unstructured":"Lu Q, Westlake CJ (2021) CLEM characterization of Rab8 and associated membrane trafficking regulators at primary cilium structures. In: Li G, Segev N (eds) Rab GTPases. Springer US, New York, NY, pp 91\u2013103"},{"key":"5810_CR49","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2007.03.053","volume":"129","author":"MV Nachury","year":"2007","unstructured":"Nachury MV, Loktev AV, Zhang Q et al (2007) A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 129:1201\u20131213. https:\/\/doi.org\/10.1016\/j.cell.2007.03.053","journal-title":"Cell"},{"key":"5810_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.mcb.2022.10.002","volume":"175","author":"P Moreno-Cruz","year":"2023","unstructured":"Moreno-Cruz P, Corral Nieto Y, Manrique Garcia L et al (2023) Protocols to induce and study ciliogenesis. Methods Cell Biol 175:1\u201315. https:\/\/doi.org\/10.1016\/bs.mcb.2022.10.002","journal-title":"Methods Cell Biol"},{"key":"5810_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-015-0066-z","volume":"11","author":"E Belluzzi","year":"2016","unstructured":"Belluzzi E, Gonnelli A, Cirnaru M-D et al (2016) LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate. Mol Neurodegener 11:1. https:\/\/doi.org\/10.1186\/s13024-015-0066-z","journal-title":"Mol Neurodegener"},{"key":"5810_CR52","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1091\/mbc.e02-03-0143","volume":"13","author":"K Hattula","year":"2002","unstructured":"Hattula K, Furuhjelm J, Arffman A, Per\u00e4nen J (2002) A Rab8-specific GDP\/GTP exchange factor is involved in actin remodeling and polarized membrane transport. Mol Biol Cell 13:3268\u20133280. https:\/\/doi.org\/10.1091\/mbc.e02-03-0143","journal-title":"Mol Biol Cell"},{"key":"5810_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1083\/jcb.123.1.35","volume":"123","author":"LA Huber","year":"1993","unstructured":"Huber LA, Pimplikar S, Parton RG et al (1993) Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma membrane. J Cell Biol 123:35\u201345. https:\/\/doi.org\/10.1083\/jcb.123.1.35","journal-title":"J Cell Biol"},{"key":"5810_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/cm.20529","volume":"68","author":"J Per\u00e4nen","year":"2011","unstructured":"Per\u00e4nen J (2011) Rab8 GTPase as a regulator of cell shape. Cytoskeleton (Hoboken) 68:527\u2013539. https:\/\/doi.org\/10.1002\/cm.20529","journal-title":"Cytoskeleton (Hoboken)"},{"key":"5810_CR55","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1093\/emboj\/18.21.5885","volume":"18","author":"T Coppola","year":"1999","unstructured":"Coppola T, Perret-Menoud V, L\u00fcthi S et al (1999) Disruption of Rab3-calmodulin interaction, but not other effector interactions, prevents Rab3 Inhibition of exocytosis. EMBO J 18:5885\u20135891. https:\/\/doi.org\/10.1093\/emboj\/18.21.5885","journal-title":"EMBO J"},{"key":"5810_CR56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/tra.12182","volume":"15","author":"VA Cazares","year":"2014","unstructured":"Cazares VA, Subramani A, Saldate JJ et al (2014) Distinct actions of Rab3 and Rab27 GTPases on late stages of exocytosis of insulin. Traffic 15:997\u20131015. https:\/\/doi.org\/10.1111\/tra.12182","journal-title":"Traffic"},{"key":"5810_CR57","doi-asserted-by":"publisher","first-page":"107040","DOI":"10.1016\/j.isci.2023.107040","volume":"26","author":"G Cui","year":"2023","unstructured":"Cui G, Jiang Z, Chen Y et al (2023) Evolutional insights into the interaction between Rab7 and RILP in lysosome motility. iScience 26:107040. https:\/\/doi.org\/10.1016\/j.isci.2023.107040","journal-title":"iScience"},{"key":"5810_CR58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb3109","volume":"17","author":"Q Lu","year":"2015","unstructured":"Lu Q, Insinna C, Ott C et al (2015) Early steps in primary cilium assembly require EHD1\/EHD3-dependent ciliary vesicle formation. Nat Cell Biol 17:228\u2013240. https:\/\/doi.org\/10.1038\/ncb3109","journal-title":"Nat Cell Biol"},{"key":"5810_CR59","doi-asserted-by":"publisher","first-page":"114955","DOI":"10.1016\/j.celrep.2024.114955","volume":"43","author":"I Saha","year":"2024","unstructured":"Saha I, Insinna C, Westlake CJ (2024) Rab11-Rab8 cascade dynamics in primary cilia and membrane tubules. Cell Rep 43:114955. https:\/\/doi.org\/10.1016\/j.celrep.2024.114955","journal-title":"Cell Rep"},{"key":"5810_CR60","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1038\/ncomms6308","volume":"5","author":"JM Gerdes","year":"2014","unstructured":"Gerdes JM, Christou-Savina S, Xiong Y et al (2014) Ciliary dysfunction impairs beta-cell insulin secretion and promotes development of type 2 diabetes in rodents. Nat Commun 5:5308. https:\/\/doi.org\/10.1038\/ncomms6308","journal-title":"Nat Commun"},{"key":"5810_CR61","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1073\/pnas.2001936117","volume":"117","author":"JW Hughes","year":"2020","unstructured":"Hughes JW, Cho JH, Conway HE et al (2020) Primary cilia control glucose homeostasis via islet paracrine interactions. Proc Natl Acad Sci U S A 117:8912\u20138923. https:\/\/doi.org\/10.1073\/pnas.2001936117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5810_CR62","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.celrep.2019.02.056","volume":"26","author":"O Kluth","year":"2019","unstructured":"Kluth O, Stadion M, Gottmann P et al (2019) Decreased expression of cilia genes in pancreatic Islets as a risk factor for type 2 diabetes in mice and humans. Cell Rep 26:3027\u20133036e3. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.056","journal-title":"Cell Rep"},{"key":"5810_CR63","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1210\/me.2005-0494","volume":"20","author":"T Arsov","year":"2006","unstructured":"Arsov T, Silva DG, O\u2019Bryan MK et al (2006) Fat Aussie\u2014A new Alstr\u00f6m syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol 20:1610\u20131622. https:\/\/doi.org\/10.1210\/me.2005-0494","journal-title":"Mol Endocrinol"},{"key":"5810_CR64","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1093\/hmg\/ddi235","volume":"14","author":"GB Collin","year":"2005","unstructured":"Collin GB, Cyr E, Bronson R et al (2005) Alms1-disrupted mice recapitulate human Alstr\u00f6m syndrome. Hum Mol Genet 14:2323\u20132333. https:\/\/doi.org\/10.1093\/hmg\/ddi235","journal-title":"Hum Mol Genet"},{"key":"5810_CR65","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3390\/biomedicines10123026","volume":"10","author":"TD Zhang","year":"2022","unstructured":"Zhang TD, Kolbe SC, Beauchamp LC et al (2022) How well do rodent models of parkinson\u2019s disease recapitulate early Non-Motor phenotypes?? Syst Rev Biomedicines 10:3026. https:\/\/doi.org\/10.3390\/biomedicines10123026","journal-title":"Syst Rev Biomedicines"},{"key":"5810_CR66","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1080\/15548627.2024.2338576","volume":"20","author":"T Zhang","year":"2024","unstructured":"Zhang T, Linghu K-G, Tan J et al (2024) TIGAR exacerbates obesity by triggering LRRK2-mediated defects in macroautophagy and chaperone-mediated autophagy in adipocytes. Autophagy 20:1741\u20131761. https:\/\/doi.org\/10.1080\/15548627.2024.2338576","journal-title":"Autophagy"},{"key":"5810_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tins.2022.03.001","volume":"45","author":"W Chen","year":"2022","unstructured":"Chen W, Cai W, Hoover B, Kahn CR (2022) Insulin action in the brain: cell types, circuits, and diseases. Trends Neurosci 45:384\u2013400. https:\/\/doi.org\/10.1016\/j.tins.2022.03.001","journal-title":"Trends Neurosci"},{"key":"5810_CR68","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ (2020) The association between type 2 diabetes mellitus and parkinson\u2019s disease. JPD 10:775\u2013789. https:\/\/doi.org\/10.3233\/JPD-191900","journal-title":"JPD"},{"key":"5810_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4951379","volume":"2019","author":"F Camargo Maluf","year":"2019","unstructured":"Camargo Maluf F, Feder D, Alves de Siqueira Carvalho A (2019) Analysis of the relationship between type II diabetes mellitus and parkinson\u2019s disease: A systematic review. Parkinson\u2019s Disease 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/4951379","journal-title":"Parkinson\u2019s Disease"},{"key":"5810_CR70","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4103\/1673-5374.332122","volume":"17","author":"CM Labandeira","year":"2022","unstructured":"Labandeira CM, Fraga-Bau A, Arias Ron D et al (2022) Parkinson\u2019s disease and diabetes mellitus: common mechanisms and treatment repurposing. Neural Regen Res 17:1652\u20131658. https:\/\/doi.org\/10.4103\/1673-5374.332122","journal-title":"Neural Regen Res"},{"key":"5810_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0304-3940(96)12357-0","volume":"204","author":"M Takahashi","year":"1996","unstructured":"Takahashi M, Yamada T, Tooyama I et al (1996) Insulin receptor mRNA in the substantia Nigra in parkinson\u2019s disease. Neurosci Lett 204:201\u2013204. https:\/\/doi.org\/10.1016\/0304-3940(96)12357-0","journal-title":"Neurosci Lett"},{"key":"5810_CR72","doi-asserted-by":"publisher","first-page":"e12760","DOI":"10.1111\/nan.12760","volume":"48","author":"F Bassil","year":"2022","unstructured":"Bassil F, Delamarre A, Canron M-H et al (2022) Impaired brain insulin signalling in parkinson\u2019s disease. Neuropathol Appl Neurobiol 48:e12760. https:\/\/doi.org\/10.1111\/nan.12760","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5810_CR73","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuroscience.2014.04.006","volume":"270","author":"JK Morris","year":"2014","unstructured":"Morris JK, Vidoni ED, Perea RD et al (2014) Insulin resistance and Gray matter volume in neurodegenerative disease. Neuroscience 270:139\u2013147. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.04.006","journal-title":"Neuroscience"},{"key":"5810_CR74","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/18715273113126660155","volume":"13","author":"MMS Lima","year":"2014","unstructured":"Lima MMS, Targa ADS, Noseda ACD et al (2014) Does parkinson\u2019s disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments? CNS Neurol Disord Drug Targets 13:418\u2013428. https:\/\/doi.org\/10.2174\/18715273113126660155","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"5810_CR75","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/BF00279918","volume":"28","author":"RA Rizza","year":"1985","unstructured":"Rizza RA, Mandarino LJ, Genest J et al (1985) Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28:70\u201375. https:\/\/doi.org\/10.1007\/BF00279918","journal-title":"Diabetologia"},{"key":"5810_CR76","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0031-9384(91)90021-F","volume":"50","author":"MB Destefano","year":"1991","unstructured":"Destefano MB, Stern JS, Castonguay TW (1991) Effect of chronic insulin administration on food intake and body weight in rats. Physiol Behav 50:801\u2013806. https:\/\/doi.org\/10.1016\/0031-9384(91)90021-F","journal-title":"Physiol Behav"},{"key":"5810_CR77","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1038\/s41598-020-66319-9","volume":"10","author":"A Thaler","year":"2020","unstructured":"Thaler A, Shenhar-Tsarfaty S, Shaked Y et al (2020) Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related parkinson\u2019s disease. Sci Rep 10:9329. https:\/\/doi.org\/10.1038\/s41598-020-66319-9","journal-title":"Sci Rep"},{"key":"5810_CR78","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","volume":"145","author":"J Galper","year":"2022","unstructured":"Galper J, Dean NJ, Pickford R et al (2022) Lipid pathway dysfunction is prevalent in patients with parkinson\u2019s disease. Brain 145:3472\u20133487. https:\/\/doi.org\/10.1093\/brain\/awac176","journal-title":"Brain"},{"key":"5810_CR79","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells9112394","volume":"9","author":"A Yilmaz","year":"2020","unstructured":"Yilmaz A, Ugur Z, Ustun I et al (2020) Metabolic profiling of CSF from people suffering from sporadic and LRRK2 parkinson\u2019s disease: A pilot study. Cells 9:2394. https:\/\/doi.org\/10.3390\/cells9112394","journal-title":"Cells"},{"key":"5810_CR80","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/PGPM.S316158","volume":"14","author":"M-H Huang","year":"2021","unstructured":"Huang M-H, Liu Y-F, Nfor ON et al (2021) Interactive association between intronic polymorphism (rs10506151) of the LRRK2 gene and type 2 diabetes on neurodegenerative diseases. Pharmgenomics Pers Med 14:839\u2013847. https:\/\/doi.org\/10.2147\/PGPM.S316158","journal-title":"Pharmgenomics Pers Med"},{"key":"5810_CR81","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/0963689717721234","volume":"26","author":"DS Kim","year":"2017","unstructured":"Kim DS, Choi H-I, Wang Y et al (2017) A new treatment strategy for parkinson\u2019s disease through the Gut\u2013Brain axis: the Glucagon-Like Peptide-1 receptor pathway. Cell Transpl 26:1560\u20131571. https:\/\/doi.org\/10.1177\/0963689717721234","journal-title":"Cell Transpl"},{"key":"5810_CR82","doi-asserted-by":"publisher","first-page":"104593","DOI":"10.1016\/j.phrs.2019.104593","volume":"152","author":"YN Paudel","year":"2020","unstructured":"Paudel YN, Angelopoulou E, Piperi C et al (2020) Emerging neuroprotective effect of Metformin in parkinson\u2019s disease: A molecular crosstalk. Pharmacol Res 152:104593. https:\/\/doi.org\/10.1016\/j.phrs.2019.104593","journal-title":"Pharmacol Res"},{"key":"5810_CR83","doi-asserted-by":"publisher","first-page":"e0224236","DOI":"10.1371\/journal.pone.0224236","volume":"14","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Pu J, Chen Y, Zhang B (2019) Decreased risk of parkinson\u2019s disease in diabetic patients with Thiazolidinediones therapy: an exploratory meta-analysis. PLoS ONE 14:e0224236. https:\/\/doi.org\/10.1371\/journal.pone.0224236","journal-title":"PLoS ONE"},{"key":"5810_CR84","doi-asserted-by":"publisher","first-page":"E595","DOI":"10.1152\/ajpendo.00236.2023","volume":"325","author":"F Folli","year":"2023","unstructured":"Folli F, Finzi G, Manfrini R et al (2023) Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic Islets. Am J Physiol Endocrinol Metab 325:E595\u2013E609. https:\/\/doi.org\/10.1152\/ajpendo.00236.2023","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05810-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:12:52Z","timestamp":1757250772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05810-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5810"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05810-w","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal protocols were approved by the University of Trento and National Ministry of Health (IACUC 793\/2016-PR).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"276"}}